The accumulation of amyloid-β (Aβ) and tau in the brains of patients with Alzheimer's disease (AD) was reported in the 1980s, and the group of diseases characterized by abnormal tau inclusions is referred to as tauopathies [46, 106, 315]. The gene discussed is MAPT; the disease is tauopathy.